|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
FY2021
12 months to Jun 30, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Loss after income tax expense for the year | |||||
| Adjustments for: | |||||
| Amortisation | |||||
| Issuance of liability classified warrants for services | |||||
| Share-based payments | |||||
| Foreign currency loss / (gain) | |||||
| Loss/(gain) on remeasurement of contingent consideration | |||||
| Interest on unwinding of contingent consideration | |||||
| Gain on remeasurement of promissory note | |||||
| Gain on remeasurement of financial assets | |||||
| Loss / (gain) on remeasurement of financial liabilities | |||||
| Impairment of intangible assets | |||||
| Cash flows from used in operations before changes in working capital | |||||
| Change in operating assets and liabilities: | |||||
| Trade and other receivables | |||||
| Other assets | |||||
| Trade and other payables | |||||
| Other provisions | |||||
| Deferred tax liability | |||||
| Borrowings | |||||
| Net cash used in operating activities | |||||
| Payment of milestone related to contingent consideration | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from issuance of shares, net of transaction costs | |||||
| Proceeds from issuance of equity and pre-funded warrants | |||||
| Proceeds from promissory note | |||||
| Net cash provided by financing activities | |||||
| Net (decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the financial year | |||||
| Effects of exchange rate changes on cash | |||||
| Cash and cash equivalents at the end of the financial year | |||||
| NON-CASH INVESTING AND FINANCING ACTIVITIES | |||||
| Conversion of convertible promissory note | |||||
| Unissued equity | |||||
| Exercise of pre-funded warrants |
Loading...
